Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Daiichi Sankyo
Farmers Insurance
Moodys
US Department of Justice
Citi
UBS
Merck
Boehringer Ingelheim

Generated: May 21, 2018

DrugPatentWatch Database Preview

Sodium benzoate; sodium phenylacetate - Generic Drug Details

or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for sodium benzoate; sodium phenylacetate and what is the scope of sodium benzoate; sodium phenylacetate patent protection?

Sodium benzoate; sodium phenylacetate
is the generic ingredient in three branded drugs marketed by Medicis, Ailex Pharms Llc, Maia Pharms Inc, Navinta Llc, and B Braun, and is included in five NDAs. Additional information is available in the individual branded drug profile pages.

There are one thousand four hundred and twenty-six drug master file entries for sodium benzoate; sodium phenylacetate. Eight suppliers are listed for this compound.
Summary for sodium benzoate; sodium phenylacetate
Pharmacology for sodium benzoate; sodium phenylacetate

US Patents and Regulatory Information for sodium benzoate; sodium phenylacetate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Maia Pharms Inc SODIUM PHENYLACETATE AND SODIUM BENZOATE sodium benzoate; sodium phenylacetate SOLUTION;IV (INFUSION) 208521-001 May 8, 2017 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Medicis AMMONUL sodium benzoate; sodium phenylacetate SOLUTION;IV (INFUSION) 020645-001 Feb 17, 2005 AP RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Navinta Llc SODIUM PHENYLACETATE AND SODIUM BENZOATE sodium benzoate; sodium phenylacetate SOLUTION;IV (INFUSION) 205880-001 Aug 4, 2016 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Ailex Pharms Llc SODIUM PHENYLACETATE AND SODIUM BENZOATE sodium benzoate; sodium phenylacetate SOLUTION;IV (INFUSION) 207096-001 Feb 24, 2016 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Chinese Patent Office
Baxter
Farmers Insurance
Mallinckrodt
Julphar
McKesson
QuintilesIMS
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.